| 1-methylphenanthrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with 1-methylphenanthrene] affects the expression of GCK mRNA | CTD | PMID:17690111 |
| 1-naphthyl isothiocyanate | decreases expression | ISO | RGD:2670 | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of GCK mRNA | CTD | PMID:17522070 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:731555 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GCK mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | decreases expression | ISO | RGD:2670 | 6480464 | Estradiol results in decreased expression of GCK mRNA | CTD | PMID:22946080 |
| 1H-pyrazole | decreases expression | ISO | RGD:731555 | 6480464 | pyrazole results in decreased expression of GCK mRNA | CTD | PMID:17945193 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:731555 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GCK mRNA | CTD | PMID:18343893 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731555 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GCK mRNA | CTD | PMID:15800033 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:2670 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GCK mRNA | CTD | PMID:16054898 PMID:23238561 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731555 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GCK mRNA | CTD | PMID:15800033 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:2670 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCK mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:2670 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GCK mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:2670 | 6480464 | AHR protein alternative form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of GCK mRNA] | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731555 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GCK mRNA | CTD | PMID:15800033 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731555 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GCK mRNA | CTD | PMID:18163543 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731555 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GCK mRNA | CTD | PMID:18295293 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731555 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GCK mRNA | CTD | PMID:18163543 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731555 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GCK mRNA | CTD | PMID:15800033 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731555 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GCK mRNA | CTD | PMID:18295293 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:2670 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GCK mRNA | CTD | PMID:16054898 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731555 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GCK mRNA | CTD | PMID:15800033 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731555 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GCK mRNA | CTD | PMID:17942748 |
| 2,4,6-trinitrotoluene | affects expression | ISO | RGD:2670 | 6480464 | Trinitrotoluene affects the expression of GCK mRNA | CTD | PMID:21346803 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:2670 | 6480464 | 2,4-dinitrotoluene affects the expression of GCK mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:2670 | 6480464 | 2,6-dinitrotoluene affects the expression of GCK mRNA | CTD | PMID:21346803 |
| 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | RGD:2670 | 6480464 | Glucosamine results in decreased expression of GCK mRNA | CTD | PMID:11893929 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | RGD:2670 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of GCK mRNA | CTD | PMID:20959002 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:731555 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of GCK mRNA | CTD | PMID:18648102 |
| 8-bromo-3',5'-cyclic AMP | decreases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GCK mRNA | CTD | PMID:22079614 |
| 9-cis-retinoic acid | decreases expression | ISO | RGD:731555 | 6480464 | alitretinoin results in decreased expression of GCK mRNA | CTD | PMID:21670153 |
| 9-cis-retinoic acid | decreases activity | ISO | RGD:2670 | 6480464 | alitretinoin results in decreased activity of GCK protein | CTD | PMID:21115832 |
| aflatoxin B1 | decreases expression | ISO | RGD:731555 | 6480464 | Aflatoxin B1 results in decreased expression of GCK mRNA | CTD | PMID:19770486 |
| aldehydo-D-glucosamine | decreases expression | ISO | RGD:2670 | 6480464 | Glucosamine results in decreased expression of GCK mRNA | CTD | PMID:11893929 |
| ammonium chloride | affects expression | ISO | RGD:2670 | 6480464 | Ammonium Chloride affects the expression of GCK mRNA | CTD | PMID:16483693 |
| anthracen-2-amine | increases expression | ISO | RGD:2670 | 6480464 | 2-anthramine results in increased expression of GCK mRNA | CTD | PMID:23038007 |
| arsenic atom | increases methylation | EXP | | 6480464 | Arsenic results in increased methylation of GCK promoter | CTD | PMID:21291286 |
| benzo[a]pyrene | decreases expression | ISO | RGD:731555 | 6480464 | Benzo(a)pyrene results in decreased expression of GCK mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with 1-methylphenanthrene] affects the expression of GCK mRNA; more ... | CTD | PMID:17690111 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:731555 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of GCK mRNA | CTD | PMID:21715664 |
| benzo[b]fluoranthene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of GCK mRNA | CTD | PMID:17690111 |
| beta-D-glucosamine | decreases expression | ISO | RGD:2670 | 6480464 | Glucosamine results in decreased expression of GCK mRNA | CTD | PMID:11893929 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:731555 | 6480464 | Diethylhexyl Phthalate results in decreased expression of GCK mRNA | CTD | PMID:19245819 |
| bisphenol A | increases expression | ISO | RGD:731555 | 6480464 | bisphenol A results in increased expression of GCK protein; more ... | CTD | PMID:21932408 |
| bisphenol A | decreases expression | ISO | RGD:2670 | 6480464 | bisphenol A results in decreased expression of GCK mRNA | CTD | PMID:22946080 PMID:23328667 |
| bisphenol A | decreases expression | ISO | RGD:2670 | 6480464 | bisphenol A results in decreased expression of GCK mRNA | CTD | PMID:22946080 |
| chloroform | increases expression | ISO | RGD:2670 | 6480464 | Chloroform results in increased expression of GCK mRNA | CTD | PMID:17522070 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:731555 | 6480464 | Ciguatoxins affects the expression of GCK mRNA | CTD | PMID:18353800 |
| clofibrate | multiple interactions | ISO | RGD:731555 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of GCK mRNA; more ... | CTD | PMID:17585979 |
| copper atom | decreases expression | ISO | RGD:731555 | 6480464 | Copper results in decreased expression of GCK mRNA | CTD | PMID:17205981 |
| copper(0) | decreases expression | ISO | RGD:731555 | 6480464 | Copper results in decreased expression of GCK mRNA | CTD | PMID:17205981 |
| D-glucose | multiple interactions | ISO | RGD:731555 | 6480464 | Glucose inhibits the reaction [Alloxan results in decreased expression of GCK mRNA] | CTD | PMID:12137914 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:731555 | 6480464 | Tetrahydrocannabinol results in increased expression of GCK protein; more ... | CTD | PMID:12237329 |
| desferrioxamine B | affects expression | ISO | RGD:2670 | 6480464 | Deferoxamine affects the expression of GCK mRNA | CTD | PMID:9761743 |
| dexamethasone | increases expression | ISO | RGD:2670 | 6480464 | Dexamethasone results in increased expression of GCK mRNA | CTD | PMID:17522070 |
| dibenz[a,h]anthracene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of GCK mRNA | CTD | PMID:17690111 |
| dibenzo[a,l]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of GCK mRNA | CTD | PMID:17690111 |
| dichlorvos | decreases activity | ISO | RGD:2670 | 6480464 | Dichlorvos results in decreased activity of GCK protein | CTD | PMID:16153661 |
| dichlorvos | increases expression | ISO | RGD:2670 | 6480464 | Dichlorvos results in increased expression of GCK mRNA | CTD | PMID:16153661 |
| diethylstilbestrol | decreases expression | ISO | RGD:2670 | 6480464 | Diethylstilbestrol results in decreased expression of GCK mRNA | CTD | PMID:22946080 |
| erythromycin estolate | decreases expression | ISO | RGD:2670 | 6480464 | Erythromycin Estolate results in decreased expression of GCK mRNA | CTD | PMID:17522070 |
| fluoranthene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of GCK mRNA | CTD | PMID:17690111 |
| fructose | increases activity | ISO | RGD:2670 | 6480464 | Fructose results in increased activity of GCK protein | CTD | PMID:20470786 |
| furan | increases methylation | ISO | RGD:2670 | 6480464 | furan results in increased methylation of GCK gene | CTD | PMID:22079235 |
| gamma-hexachlorocyclohexane | increases expression | ISO | RGD:2670 | 6480464 | Lindane results in increased expression of GCK mRNA | CTD | PMID:17785943 |
| glucose | multiple interactions | ISO | RGD:731555 | 6480464 | Glucose inhibits the reaction [Alloxan results in decreased expression of GCK mRNA] | CTD | PMID:12137914 |
| heptadecafluorononanoic acid | decreases expression | ISO | RGD:2670 | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of GCK mRNA | CTD | PMID:22387981 |
| hydrazine | decreases expression | ISO | RGD:2670 | 6480464 | hydrazine results in decreased expression of GCK mRNA | CTD | PMID:15370871 |
| imatinib | multiple interactions | EXP | | 6480464 | [imatinib co-treated with tetraarsenic tetrasulfide] results in decreased expression of GCK mRNA | CTD | PMID:19208803 |
| imatinib | decreases expression | EXP | | 6480464 | imatinib results in decreased expression of GCK mRNA | CTD | PMID:19208803 |
| microcystin-LR | increases expression | ISO | RGD:731555 | 6480464 | cyanoginosin LR results in increased expression of GCK mRNA | CTD | PMID:17654400 |
| N-ethyl-N-nitrosourea | increases mutagenesis | ISO | RGD:731555 | 6480464 | Ethylnitrosourea results in increased mutagenesis of GCK exon | CTD | PMID:15161764 |
| N-ethyl-N-nitrosourea | increases mutagenesis | ISO | RGD:731555 | 6480464 | Ethylnitrosourea results in increased mutagenesis of GCK gene | CTD | PMID:18056790 more ... |
| N-ethyl-N-nitrosourea | increases mutagenesis | ISO | RGD:731555 | 6480464 | Ethylnitrosourea results in increased mutagenesis of GCK gene | CTD | PMID:18056790 more ... |
| N-ethyl-N-nitrosourea | increases mutagenesis | ISO | RGD:731555 | 6480464 | Ethylnitrosourea results in increased mutagenesis of GCK gene | CTD | PMID:15102714 more ... |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2670 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of GCK mRNA | CTD | PMID:18164116 |
| N-nitrosodimethylamine | decreases expression | ISO | RGD:2670 | 6480464 | Dimethylnitrosamine results in decreased expression of GCK mRNA | CTD | PMID:17072980 |
| paracetamol | multiple interactions | ISO | RGD:731555 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of GCK mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | affects expression | ISO | RGD:731555 | 6480464 | Acetaminophen affects the expression of GCK mRNA | CTD | PMID:17562736 |
| perfluorooctane-1-sulfonic acid | affects expression | ISO | RGD:731555 | 6480464 | perfluorooctane sulfonic acid affects the expression of GCK mRNA | CTD | PMID:19429403 |
| perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:2670 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of GCK mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | affects expression | ISO | RGD:731555 | 6480464 | perfluorooctanoic acid affects the expression of GCK mRNA | CTD | PMID:19429403 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:2670 | 6480464 | perfluorooctanoic acid results in decreased expression of GCK mRNA | CTD | PMID:19162173 |
| phenobarbital | decreases expression | ISO | RGD:2670 | 6480464 | Phenobarbital results in decreased expression of GCK mRNA | CTD | PMID:19162173 |
| pirinixic acid | multiple interactions | ISO | RGD:731555 | 6480464 | [pirinixic acid co-treated with PPARA] results in decreased expression of GCK mRNA | CTD | PMID:20813756 |
| pirinixic acid | decreases expression | ISO | RGD:731555 | 6480464 | pirinixic acid results in decreased expression of GCK mRNA | CTD | PMID:15302862 more ... |
| pirinixic acid | decreases expression | ISO | RGD:731555 | 6480464 | pirinixic acid results in decreased expression of GCK mRNA | CTD | PMID:20813756 more ... |
| pirinixic acid | decreases expression | ISO | RGD:731555 | 6480464 | pirinixic acid results in decreased expression of GCK mRNA | CTD | PMID:15302862 more ... |
| pirinixic acid | decreases expression | ISO | RGD:731555 | 6480464 | pirinixic acid results in decreased expression of GCK mRNA | CTD | PMID:20813756 more ... |
| resveratrol | multiple interactions | ISO | RGD:2670 | 6480464 | resveratrol inhibits the reaction [INS1 protein results in increased expression of GCK mRNA] | CTD | PMID:16626303 |
| resveratrol | decreases expression | ISO | RGD:2670 | 6480464 | resveratrol results in decreased expression of GCK mRNA; more ... | CTD | PMID:19740748 |
| resveratrol | decreases activity | ISO | RGD:2670 | 6480464 | resveratrol results in decreased activity of GCK protein | CTD | PMID:19740748 |
| resveratrol | multiple interactions | ISO | RGD:2670 | 6480464 | FOXO1 protein promotes the reaction [resveratrol results in decreased activity of GCK protein]; more ... | CTD | PMID:19740748 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of GCK mRNA | CTD | PMID:21163946 |
| resveratrol | multiple interactions | EXP | | 6480464 | 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein promotes the reaction [resveratrol results in increased expression of GCK mRNA]] | CTD | PMID:21163946 |
| rosiglitazone | multiple interactions | ISO | RGD:2670 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of GCK mRNA]; more ... | CTD | PMID:18191635 |
| rosiglitazone | increases expression | ISO | RGD:2670 | 6480464 | rosiglitazone results in increased expression of GCK protein; more ... | CTD | PMID:18191635 |
| sevoflurane | affects expression | ISO | RGD:2670 | 6480464 | sevoflurane affects the expression of GCK mRNA | CTD | PMID:15967596 |
| tamoxifen | affects expression | ISO | RGD:731555 | 6480464 | Tamoxifen affects the expression of GCK mRNA | CTD | PMID:20937368 |
| testosterone | increases expression | ISO | RGD:731555 | 6480464 | Testosterone results in increased expression of GCK mRNA | CTD | PMID:20403060 |
| tetrachloromethane | decreases expression | ISO | RGD:2670 | 6480464 | Carbon Tetrachloride results in decreased expression of GCK mRNA | CTD | PMID:17522070 |
| theophylline | increases expression | ISO | RGD:2670 | 6480464 | Theophylline results in increased expression of GCK mRNA | CTD | PMID:17522070 |
| trans-resveratrol | multiple interactions | ISO | RGD:2670 | 6480464 | resveratrol inhibits the reaction [INS1 protein results in increased expression of GCK mRNA] | CTD | PMID:16626303 |
| trans-resveratrol | decreases expression | ISO | RGD:2670 | 6480464 | resveratrol results in decreased expression of GCK mRNA; more ... | CTD | PMID:19740748 |
| trans-resveratrol | decreases activity | ISO | RGD:2670 | 6480464 | resveratrol results in decreased activity of GCK protein | CTD | PMID:19740748 |
| trans-resveratrol | multiple interactions | ISO | RGD:2670 | 6480464 | FOXO1 protein promotes the reaction [resveratrol results in decreased activity of GCK protein]; more ... | CTD | PMID:19740748 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of GCK mRNA | CTD | PMID:21163946 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [SIRT1 protein promotes the reaction [resveratrol results in increased expression of GCK mRNA]] | CTD | PMID:21163946 |